Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas

The targeted therapy combination beat chemotherapy on progression-free survival, but there was no difference in overall survival at the interim analysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/989785?src=rss